Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 2
1988 2
1989 3
1995 2
1996 4
1997 1
1998 5
1999 1
2000 1
2001 4
2002 2
2003 4
2004 5
2005 4
2006 4
2007 5
2008 4
2009 6
2010 12
2011 15
2012 25
2013 28
2014 37
2015 23
2016 23
2017 16
2018 29
2019 25
2020 12
2021 9
2022 10
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 24331655

278 results

Results by year

Filters applied: . Clear all
Page 1
RTOG 0417: efficacy of bevacizumab in combination with definitive radiation therapy and cisplatin chemotherapy in untreated patients with locally advanced cervical carcinoma.
Schefter T, Winter K, Kwon JS, Stuhr K, Balaraj K, Yaremko BP, Small W Jr, Sause W, Gaffney D; Radiation Therapy Oncology Group (RTOG). Schefter T, et al. Int J Radiat Oncol Biol Phys. 2014 Jan 1;88(1):101-5. doi: 10.1016/j.ijrobp.2013.10.022. Int J Radiat Oncol Biol Phys. 2014. PMID: 24331655 Clinical Trial.
A phase II study of bevacizumab in combination with definitive radiotherapy and cisplatin chemotherapy in untreated patients with locally advanced cervical carcinoma: preliminary results of RTOG 0417.
Schefter TE, Winter K, Kwon JS, Stuhr K, Balaraj K, Yaremko BP, Small W Jr, Gaffney DK. Schefter TE, et al. Int J Radiat Oncol Biol Phys. 2012 Jul 15;83(4):1179-84. doi: 10.1016/j.ijrobp.2011.10.060. Epub 2012 Feb 16. Int J Radiat Oncol Biol Phys. 2012. PMID: 22342094 Clinical Trial.
Feasibility and acute toxicity of Concurrent Chemoradiotherapy (CCRT) with high-dose rate intracavitary brachytherapy (HDR-ICBT) and 40-mg/m2 weekly cisplatin for Japanese patients with cervical cancer: results of a Multi-Institutional Phase 2 Study (JGOG1066).
Toita T, Kitagawa R, Hamano T, Umayahara K, Hirashima Y, Aoki Y, Oguchi M, Mikami M, Takizawa K; Cervical Cancer Vulva Cancer Committee of the Japanese Gynecologic Oncology Group. Toita T, et al. Int J Gynecol Cancer. 2012 Oct;22(8):1420-6. doi: 10.1097/IGC.0b013e3182647265. Int J Gynecol Cancer. 2012. PMID: 22932262 Clinical Trial.
Clinical outcomes of definitive chemoradiation followed by intracavitary pulsed-dose rate image-guided adaptive brachytherapy in locally advanced cervical cancer.
Castelnau-Marchand P, Chargari C, Maroun P, Dumas I, Del Campo ER, Cao K, Petit C, Martinetti F, Tafo-Guemnie A, Lefkopoulos D, Morice P, Haie-Meder C, Mazeron R. Castelnau-Marchand P, et al. Gynecol Oncol. 2015 Nov;139(2):288-94. doi: 10.1016/j.ygyno.2015.09.008. Epub 2015 Sep 11. Gynecol Oncol. 2015. PMID: 26364808
278 results